These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New approaches to managing psychotic depression. Schatzberg AF J Clin Psychiatry; 2003; 64 Suppl 1():19-23. PubMed ID: 12625801 [TBL] [Abstract][Full Text] [Related]
4. Current and emerging somatic treatment strategies in psychotic major depression. Dannon PN; Lowengrub K; Gonopolski Y; Kotler M Expert Rev Neurother; 2006 Jan; 6(1):73-80. PubMed ID: 16466314 [TBL] [Abstract][Full Text] [Related]
5. Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder. Papakostas GI Essent Psychopharmacol; 2005; 6(4):209-20. PubMed ID: 16041917 [TBL] [Abstract][Full Text] [Related]
6. Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features. Andreescu C; Mulsant BH; Peasley-Miklus C; Rothschild AJ; Flint AJ; Heo M; Caswell M; Whyte EM; Meyers BS; J Clin Psychiatry; 2007 Feb; 68(2):194-200. PubMed ID: 17335316 [TBL] [Abstract][Full Text] [Related]
7. Challenges in the treatment of major depressive disorder with psychotic features. Rothschild AJ Schizophr Bull; 2013 Jul; 39(4):787-96. PubMed ID: 23599251 [TBL] [Abstract][Full Text] [Related]
8. The treatment of psychotic major depressive disorder with drugs and electroconvulsive therapy. Minter RE; Mandel MR J Nerv Ment Dis; 1979 Dec; 167(12):726-33. PubMed ID: 41882 [TBL] [Abstract][Full Text] [Related]
9. [Antidepressive agents in the elderly]. de Hooge JK Tijdschr Gerontol Geriatr; 1990 Dec; 21(6):259-67. PubMed ID: 1980385 [TBL] [Abstract][Full Text] [Related]
14. Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders. Oshima A; Higuchi T; Fujiwara Y; Iida M; Iwanami A; Kanba S; Motohashi N; Uchitomi Y; Yamada K; Yamawaki S Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S67-72. PubMed ID: 10560902 [TBL] [Abstract][Full Text] [Related]
15. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression. Hamoda HM; Osser DN Harv Rev Psychiatry; 2008; 16(4):235-47. PubMed ID: 18661366 [TBL] [Abstract][Full Text] [Related]
16. Antidepressant treatment of psychotic major depression: potential role of the sigma receptor. Stahl SM CNS Spectr; 2005 Apr; 10(4):319-23. PubMed ID: 15788959 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of newer treatment interventions for psychotic depression. O'Neal BL; Smith CL; Trivedi M Curr Psychiatry Rep; 2000 Aug; 2(4):305-9. PubMed ID: 11122973 [TBL] [Abstract][Full Text] [Related]
18. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials. McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275 [TBL] [Abstract][Full Text] [Related]
19. Antidepressant and antipsychotic treatment of Psychotic Major Depression in a British mental healthcare setting. Jami ES; Pritchard M; Shetty H; Stewart R; Young AH; Heslin M J Ment Health; 2023 Feb; 32(1):71-77. PubMed ID: 33961752 [TBL] [Abstract][Full Text] [Related]
20. The treatment of psychotic depression. Coryell W J Clin Psychiatry; 1998; 59 Suppl 1():22-7; discussion 28-9. PubMed ID: 9448666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]